Diagnostic Accuracy of FDG PET/CT for Lymph Node Metastasis in Non-small Cell Lung Cancer

Diagnostic Accuracy of FDG PET/CT for Lymph Node Metastasis in Non-small Cell Lung Cancer: A Single Center Study from Eastern Thailand

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250904001

Enrollment

Registered

2025-09-04

Start date

2020-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer. FDG PET/CT, lung cancer, Thailand, nodal metastasis, lymph node metastasis, non-small cell

Interventions

Non-small cell lung cancer patients who underwent FDG PET/CT for primary staging and had negative results for mediastinal lymph nodes and were confirmed with histology. The confirmed histology could b

Diagnostic,Diagnostic

Benign lymph nodes,Metastatic lymph nodes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non-small cell lung cancer patients who underwent FDG PET/CT for primary staging and had confirmed histology for mediastinal lymph nodes. No treatment before FDG PET/CT or tissue acquisition is received

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
Accuracy Surgery FDG PET/CT	—

Secondary

Measure	Time frame
SUVmax Surgery FDG PET/CT,Risk factor for lymph node metastasis Surgery Multivariate analysis	—

Countries

Thailand

Contacts

Public ContactWasit Kanokwongnuwat

Phrapokklao Hospital

wasitov@gmail.com039319666

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026